Analysis of Clinical Manifestations and Prognosis of 92 Cases with Non-Hodgkin's Lymphoma

References

1. ↵
   1. Rueffer U,
   2. Josting A, et al.

   Non-Hodgkin’s lymphoma after primary Hodgkin’s disease in the German Hodgkin’s Lymphoma Study Group: Incidence, Treatment, and Prognosis. J Clin Oncol 2001; 19: 2026-2035.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Xu RH,
   2. Jiang WQ,
   3. Li YH, et al.

   Curative effect on aggressive B cell non-Hodgkin's lymphoma and relevant influencing factors of its prognosis, a study of 203 cases. Zhonghua Yi Xue Za Zhi 2003; 83: 191-194 (Chinese).

   OpenUrlPubMed
3. ↵
   1. Chim CS,
   2. Ma SY,
   3. Au WY, et al.

   Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004; 103: 216-218.

   OpenUrlAbstract/FREE Full Text
4. ↵
   1. Shi YK.

   New opinion on clinical treatment of non-Hodgkin’s lymphoma. Bai Xue Bing-Lin Ba Liu 2001; 10: 323-324 (Chinese).

   OpenUrl
5. ↵
   1. Dumoutet C,
   2. Mounier N,
   3. Munck JN, et al.

   Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgekin lymphoma: a GELA study. Br J Haematol 2002; 118: 210-217.

   OpenUrlCrossRefPubMedWeb of Science
6. 1. Younes A,
   2. Preti HA,
   3. Hagemeister FB.

   Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma. Ann Oncol 2001; 12: 923-927.

   OpenUrlPubMed
7. ↵
   1. Narayanasami U,
   2. Kanteti R,
   3. Morelli J, et al.

   Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood 2001; 98: 2059-2064.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Liu KY,
   2. Lu DP.

   Clinical analysis of autologous peripheral blood stem cell transplantation in 182 patients with non-Hodgkin’s lymphoma. Zhonghua Nei Ke Za Zhi 2002; 41: 363-366 (Chinese).

   OpenUrlPubMed
9. 1. Su Y,
   2. Zheng HJ,
   3. Zhao YH, et al.

   Clinical effect of autologous peripheral blood stem cell transplantation on treatment of refractory malignant lymphoma. Zhong-guo Zhong Liu Lin Chuang 2001; 28: 835-837 (Chinese).

   OpenUrl
10. ↵
    1. Huang HQ,
    2. Peng YL,
    3. Lin XB, et al.

    Analysis for a longterm follow-up of CHOP regimen in treating 106 cases with peripheral T-cell lymphoma. Ai Zheng 2004; 23: 1443-1447 (Chinese).

    OpenUrlPubMed